基础医学与临床 ›› 2017, Vol. 37 ›› Issue (4): 548-552.
• 短篇综述 • 上一篇 下一篇
徐周纬1,严尚学2,吴华勋2,陈镜宇2,张影2,魏伟2
收稿日期:
修回日期:
出版日期:
发布日期:
通讯作者:
基金资助:
Received:
Revised:
Online:
Published:
Contact:
Supported by:
摘要: G蛋白偶联受体激酶2(GRK2)属于丝氨酸/苏氨酸蛋白激酶家族,广泛分布于各种组织中,能够特异性的使活化的G蛋白偶联受体(GPCRs)发生磷酸化及脱敏,从而终止GPCRs介导的信号转导通路。GRK2不仅能够调节GPCRs和非GPCRs,其自身活性和表达也可受到多种因素的调节。GRK2具有多种不同的生理及病理作用,其涉及的许多信号通路与恶性肿瘤的发生发展密切相关。
关键词: G蛋白偶联受体, G蛋白偶联受体激酶2, 活性调控, 表达调控, 恶性肿瘤
Abstract: G protein-coupled receptor kinases 2 (GRK2), which belongs to the serine/threonine protein kinase family, is widely distributed in a variety of tissues.With its specificity, it can enable activated G protein-coupled receptors (GPCRs) to be phosphorylated and desensitized, thus terminating the signal transduction pathways mediated by GPCRs.GRK2 can modulate GPCRs and non-GPCRs, but its own activity and expression may also be subject to the regulation of a number of factors. GRK2 has a variety of physiological and pathological effects, and many signaling pathways involved are closely related to the occurrence and development of malignant tumors.
Key words: G protein coupled receptors, G protein coupled receptor kinase 2, activity regulation, expression regulation, malignant tumor
徐周纬 严尚学 吴华勋 陈镜宇 张影 魏伟. G蛋白偶联受体激酶2活性和表达的调控及其在恶性肿瘤中的作用[J]. 基础医学与临床, 2017, 37(4): 548-552.
/ 推荐
导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks
链接本文: https://journal11.magtechjournal.com/Jwk_jcyxylc/CN/
https://journal11.magtechjournal.com/Jwk_jcyxylc/CN/Y2017/V37/I4/548